Loading…
Loading…
The British Business Bank (BBB) committed GBP 34 million as a fund investor in WestBridge III, the third fund raised by WestBridge, a lower-mid-market UK private equity firm with offices in London, Manchester and Cardiff. The commitment helped WestBridge III reach its GBP 225 million hard cap. WestBridge's strategy targets high-growth, tech-enabled B2B services companies with proven profitability across the UK's Nations and regions (explicitly outside London and the South East), typically writing cheques of GBP 10-40 million to help portfolio companies scale internationally. The Bank previously backed WestBridge II in 2017 with a GBP 15 million commitment (final close GBP 102 million); across its three funds WestBridge has now raised GBP 266 million invested in 23 companies.
This is a regional-growth-equity fund-of-funds commitment rather than a sector-targeted industrial-strategy allocation (contrast with the life-sciences-specific SV8 Biotech Fund commitment filed as 2025-12-08-uk-british-business-bank-sv8-biotech-fund-commitment), but sits in the same BBB pattern of crowding in private capital behind regional/SME growth equity that underpins the UK's Modern Industrial Strategy ("Invest 2035", Command Paper CP 1451).
single-company stake; severity set at 1, consistent with prior BBB fund-commitment filings of similar scale.
mandate as a recurring instrument of UK industrial policy, distinct from sector-specific vehicles (life sciences, biotech).
commitment, classified "Red"/certainly harmful); no export- or trade-control dimension is present.
during 2026 and how it compares in per-company ticket size to prior WestBridge funds.
commitments at this cadence through 2026 as part of its CP 1451 capital uplift.